Cardiorenal syndrome type 1: Pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure

Journal of the American College of Cardiology

Volumn 60, Issue 12, 2012, Pages 1031-1042

  Ronco, Claudio ^a,b   Cicoira, Mariantonietta ^c   McCullough, Peter A ^d,e,f,g  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d St John Providence Health System   (United States)

^e PROVIDENCE HOSPITAL   (United States)

^f ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^g Providence Park Heart Institute   (United States)

Author keywords

acute kidney injury; cardiorenal syndrome; fluid overload; heart failure; hemodialysis; hemofiltration; oliguria; refractory edema; ultrafiltration

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ARGIPRESSIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINATED CONTRAST MEDIUM; LOOP DIURETIC AGENT; METFORMIN; NEUROHORMONE; RENIN;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ANEMIA; CACHEXIA; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOTOXEMIA; GLOMERULUS FILTRATION; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEMODYNAMIC PARAMETERS; HORMONAL REGULATION; HOSPITAL PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOVOLEMIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; LACTIC ACIDOSIS; OBESITY; OLIGURIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; SUPERINFECTION; TUBULAR DYSFUNCTION; TUMOR LYSIS SYNDROME; UREMIA; URIC ACID BLOOD LEVEL; VENOUS CONGESTION;

ACUTE DISEASE; ANIMALS; CARDIO-RENAL SYNDROME; HEART FAILURE; HUMANS; KIDNEY DISEASES; RENAL INSUFFICIENCY;

EID: 84866097695     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.01.077     Document Type: Review

References (112)

1. C. Ronco, P. McCullough, S.D. Anker Acute Dialysis Quality Initiative (ADQI) Consensus Group Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative Eur Heart J 31 2010 703 711
2. P.A. McCullough, M. Haapio, S. Mankad Acute Dialysis Quality Initiative (ADQI) Consensus Group Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference Nephrol Dial Transplant 25 2010 1777 1784
3. C. Ronco, P.A. McCullough, S.D. Anker Acute Dialysis Quality Initiative (ADQI) Consensus Group Cardiorenal syndromes: an executive summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Contrib Nephrol 165 2010 54 67
4. N. Hata, S. Yokoyama, T. Shinada Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population Eur J Heart Fail 12 2010 32 37
5. S.M. Bagshaw, D.N. Cruz, N. Aspromonte Acute Dialysis Quality Initiative (ADQI) Consensus Group Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference Nephrol Dial Transplant 25 2010 1406 1416
6. K. Damman, G. Navis, A.A. Voors Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608 (Pubitemid 47513536)
7. P.A. McCullough Cardiorenal syndromes: pathophysiology to prevention Int J Nephrol 2010 2010 762590
8. A.A. House, I. Anand, R. Bellomo Acute Dialysis Quality Initiative (ADQI) Consensus Group Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference Nephrol Dial Transplant 25 2010 1416 1420
9. V. Agrawal, K.R. Krause, D.L. Chengelis, K.C. Zalesin, L.L. Rocher, P.A. McCullough Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein Surg Obes Relat Dis 5 2009 20 26
10. D.M. Ouwens, H. Sell, S. Greulich, J. Eckel The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease J Cell Mol Med 14 2010 2223 2234
11. M.R. Movahed, Y. Saito Obesity is associated with left atrial enlargement, E/A reversal and left ventricular hypertrophy Exp Clin Cardiol 13 2008 89 91 (Pubitemid 351865320)
12. M. Praga, E. Morales Obesity, proteinuria and progression of renal failure Curr Opin Nephrol Hypertens 15 2006 481 486
13. T.E. Hunley, L.J. Ma, V. Kon Scope and mechanisms of obesity-related renal disease Curr Opin Nephrol Hypertens 19 2010 227 234
14. L.G. Glance, R. Wissler, D.B. Mukamel Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery Anesthesiology 113 2010 859 872
15. M. Cicoira, A.P. Bolger, W. Doehner High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients Cytokine 15 2001 80 86 (Pubitemid 34920508)
16. A. Palazzuoli, M. Beltrami, S. Nodari, P.A. McCullough, C. Ronco Clinical impact of renal dysfunction in heart failure Rev Cardiovasc Med 12 2011 186 199
17. P.A. McCullough Micronutrients and cardiorenal disease: insights into novel assessments and treatment Blood Purif 31 2011 177 185
18. P.A. McCullough, S. Li, C.T. Jurkovitz Kidney Early Evaluation Program Investigators CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004 Am J Kidney Dis 51 Suppl 2 2008 S38 S45
19. P.D. Hart, G.L. Bakris Hypertensive nephropathy: prevention and treatment recommendations Expert Opin Pharmacother 11 2010 2675 2686
20. D.E. Forman, J. Butler, Y. Wang Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67 (Pubitemid 38045917)
21. D.G. Warnock, P. Muntner, P.A. McCullough REGARDS Investigators Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study Am J Kidney Dis 56 2010 861 871
22. S. Blecker, K. Matsushita, A. Köttgen High-normal albuminuria and risk of heart failure in the community Am J Kidney Dis 58 2011 47 55
23. C.E. Jackson, S.D. Solomon, H.C. Gerstein CHARM Investigators and Committees Albuminuria in chronic heart failure: prevalence and prognostic importance Lancet 374 2009 543 550
24. S.M. Periyasamy, J. Chen, D. Cooney Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function Kidney Int 60 2001 2367 2376 (Pubitemid 33070481)
25. R. Dikow, U. Schmidt, L.P. Kihm Uremia aggravates left ventricular remodeling after myocardial infarction Am J Nephrol 32 2010 13 22
26. L.M. Ruilope, J. Garcia-Puig Hyperuricemia and renal function Curr Hypertens Rep 3 2001 197 202
27. D.I. Feig, D.H. Kang, R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
28. G. Thanassoulis, J.M. Brophy, H. Richard, L. Pilote Gout, allopurinol use, and heart failure outcomes Arch Intern Med 170 2010 1358 1364
29. A. Noman, D.S. Ang, S. Ogston, C.C. Lang, A.D. Struthers Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial Lancet 375 2010 2161 2167
30. M. Goicoechea, S.G. de Vinuesa, U. Verdalles Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Clin J Am Soc Nephrol 5 2010 1388 1393
31. D.S. Silverberg The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome Heart Fail Rev 16 2011 609 614
32. M. Abe, K. Okada, T. Maruyama, N. Maruyama, K. Matsumoto, M. Soma Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammation-atherosclerosis (MIA) syndrome in hemodialysis patients with diabetes Int J Artif Organs 34 2011 16 25
33. A. Palazzuoli, G. Antonelli, R. Nuti Anemia in cardio-renal syndrome: clinical impact and pathophysiologic mechanisms Heart Fail Rev 16 2011 603 607
34. A. Kato Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome Future Cardiol 6 2010 769 771
35. K. van der Putten, K.E. Jie, D. van den Broek Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients Eur J Heart Fail 12 2010 943 950
36. D.S. Silverberg, D. Wexler, A. Iaina, D. Schwartz Anaemia management in cardio renal disease J Ren Care 36 Suppl 1 2010 86 96
37. S.D. Anker, J. Comin Colet, G. Filippatos FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
38. P.S. Parfrey Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure Curr Opin Nephrol Hypertens 20 2011 177 181
39. M. Haase, R. Bellomo, A. Haase-Fielitz Neutrophil gelatinase-associated lipocalin: a superior biomarker for detection of subclinical acute kidney injury and poor prognosis Biomark Med 5 2011 415 417
40. M. Haase, P. Devarajan, A. Haase-Fielitz The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies J Am Coll Cardiol 57 2011 1752 1761
41. E.E. Creemers, Y.M. Pinto Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart Cardiovasc Res 89 2011 265 272
42. P.A. McCullough, A. Olobatoke, T.E. Vanhecke Galectin-3: a novel blood test for the evaluation and management of patients with heart failure Rev Cardiovasc Med 12 2011 200 210
43. J. Dumic, S. Dabelic, M. Flögel Galectin-3: an open-ended story Biochim Biophys Acta 1760 2006 616 635 (Pubitemid 44382499)
44. A. Krześlak, A. Lipiska Galectin-3 as a multifunctional protein Cell Mol Biol Lett 9 2004 305 328 (Pubitemid 38902225)
45. J. Raimond, D.B. Zimonjic, C. Mignon Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22 Mamm Genome 8 1997 706 707 (Pubitemid 28060633)
46. N.C. Henderson, T. Sethi The regulation of inflammation by galectin-3 Immunol Rev 230 2009 160 171
47. C. Schrimpf, J.S. Duffield Mechanisms of fibrosis: the role of the pericyte Curr Opin Nephrol Hypertens 20 2011 297 305
48. U.C. Sharma, S. Pokharel, T.J. van Brakel Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction Circulation 110 2004 3121 3128 (Pubitemid 39492008)
49. J.T. Heywood The cardiorenal syndrome: lessons from the ADHERE database and treatment options Heart Fail Rev 9 2004 195 201
50. L.G. Bongartz, M.J. Cramer, P.A. Doevendans, J.A. Joles, B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur Heart J 26 2005 11 17 (Pubitemid 40221118)
51. F.B. Winton The influence of venous pressure on the isolated mammalian kidney Am J Physiol 463 1931 612 644
52. W. Mullens, Z. Abrahams, G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
53. A. Nohria, V. Hasselblad, A. Stebbins Cardiorenal interactions: insights from the ESCAPE trial J Am Coll Cardiol 51 2008 1268 1274 (Pubitemid 351400890)
54. K.V. Liang, A.W. Williams, E.L. Greene, M.M. Redfield Acute decompensated heart failure and the cardiorenal syndrome Crit Care Med 36 Suppl 1 2008 S75 S88
55. G.S. Francis, K.M. McDonald, J.N. Cohn Neurohumoral activation in preclinical heart failure Remodeling and the potential for intervention Circulation 87 Suppl 5 1993 IV90 IV96
56. W.C. Burns, M.C. Thomas Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease Cells Tissues Organs 193 2011 74 84
57. M. Cicoira, L. Zanolla, A. Rossi Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype J Am Coll Cardiol 37 2001 1808 1812 (Pubitemid 32499963)
58. M. Cicoira, L. Zanolla, L. Franceschini Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 403 407 (Pubitemid 34142514)
59. R.A. de Boer, A.A. Voors, P. Muntendam, W.H. van Gilst, D.J. van Veldhuisen Galectin-3: a novel mediator of heart failure development and progression Eur J Heart Fail 11 2009 811 817
60. B.F. Palmer Pathogenesis of ascites and renal salt retention in cirrhosis J Investig Med 47 1999 183 202 (Pubitemid 129576363)
61. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, J. Butler The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 3 54 2009 1747 1752
62. U.C. Kopp, G.F. DiBona Neural regulation of renin secretion Semin Nephrol 13 1993 543 551 (Pubitemid 23336192)
63. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241 (Pubitemid 20225044)
64. G. Torre-Amione Immune activation in chronic heart failure Am J Cardiol 95 2005 3C 8C (Pubitemid 40755512)
65. R. Ferrari, T. Bachetti, R. Confortini Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure Circulation 92 1995 1479 1486
66. P. Aukrust, T. Ueland, E. Lien Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 83 1999 376 382 (Pubitemid 29066497)
67. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, D.L. Mann Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST) Circulation 103 2001 2055 2059 (Pubitemid 32373007)
68. A. Mantovani, C. Garlanda, B.P. Bottazzi The long pentraxin PTX3 in vascular pathology Vascul Pharmacol 45 2006 326 330 (Pubitemid 44765293)
69. S. Frantz, G. Ertl, J. Bauersachs Mechanisms of disease: toll-like receptors in cardiovascular disease Nat Clin Pract Cardiovasc Med 4 2007 444 454 (Pubitemid 47180328)
70. L. Gullestad, P. Aukrust Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches Am J Cardiol 95 2005 17C 23C discussion 38C-40C (Pubitemid 40755514)
71. D.L. Mann, J.J. McMurray, M. Packer Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602 (Pubitemid 38451714)
72. S.D. Anker, A.J. Coats How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH Int J Cardiol 86 2002 123 130 (Pubitemid 35284800)
73. S. Heymans, E. Hirsch, S.D. Anker Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 11 2009 119 129
74. M. Rauchhaus, W. Doehner, D.P. Francis Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
75. O. Milo, G. Cotter, E. Kaluski Inflammatory and neurohormonal activation in cardiogenic pulmonary edema: implications on the pathogenesis and outcome of acute ischemic versus non-ischemic acute heart failure Am J Cardiol 92 2003 222 226 (Pubitemid 36835978)
76. P.C. Colombo, J.E. Banchs, S. Celaj Endothelial cell activation in patients with decompensated heart failure Circulation 111 2005 58 62 (Pubitemid 40070844)
77. G.M. Mutlu, J.I. Sznajder Mechanisms of pulmonary edema clearance Am J Physiol Lung Cell Mol Physiol 289 2005 L685 L695
78. G. Cotter, M. Metra, O. Milo-Cotter, H.C. Dittrich, M. Gheorghiade Fluid overload in acute heart failure: re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail 10 2008 165 169 (Pubitemid 351222743)
79. A. Sandek, M. Rauchhaus, S.D. Anker, S. von Haehling The emerging role of the gut in chronic heart failure Curr Opin Clin Nutr Metab Care 11 2008 632 639
80. E.J. Kraut, S. Chen, N.E. Hubbard, K.L. Erickson, D.H. Wisner Tumor necrosis factor depresses myocardial contractility in endotoxemic swine J Trauma 46 1999 900 906 (Pubitemid 29228131)
81. A. Kumar, R. Brar, P. Wang Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol 276 1999 R265 R276
82. B.S. Cain, D.R. Meldrum, C.A. Dinarello Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function Crit Care Med 27 1999 1309 1318 (Pubitemid 29379369)
83. T.W. Perry, M.J. Pugh, G.W. Waterer Incidence of cardiovascular events after hospital admission for pneumonia Am J Med 124 2011 244 251
84. R. Murugan, V. Karajala-Subramanyam, M. Lee Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival Kidney Int 77 2010 527 535
85. T.T. van Sloten, E. Pijpers, C.D. Stehouwer, M.C. Brouwers Metformin-associated lactic acidosis in a patient with normal kidney function Diabetes Res Clin Pract 96 2012 e57 e58
86. D. Arroyo, R. Melero, N. Panizo Metformin-associated acute kidney injury and lactic acidosis Int J Nephrol 2011 2011 749653
87. N.H. Lameire, C.D. Flombaum, D. Moreau, C. Ronco Acute renal failure in cancer patients Ann Med 37 2005 13 25 (Pubitemid 40342421)
88. H. Alcaíno, D. Greig, P. Castro [The role of uric acid in heart failure] Rev Med Chil 139 2011 505 515
89. J.R. Prowle, Y.L. Liu, E. Licari Oliguria as predictive biomarker of acute kidney injury in critically ill patients Crit Care 15 2011 R172
90. P.A. McCullough Radiocontrast-induced acute kidney injury Nephron Physiol 109 2008 61 72
91. R. Mehran, S. Brar, G. Dangas Contrast-induced acute kidney injury Underappreciated or a new marker of cardiovascular mortality? J Am Coll Cardiol 55 2010 2210 2211
92. M. Haase, R. Bellomo, P. Devarajan, P. Schlattmann, A. Haase-Fielitz NGAL Meta-analysis Investigator Group Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis Am J Kidney Dis 54 2009 1012 1024
93. M. Alvelos, R. Pimentel, E. Pinho Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward Clin J Am Soc Nephrol 6 2011 476 481
94. C. Ronco, A. Maisel Volume overload and cardiorenal syndromes Congest Heart Fail 16 Suppl 1 2010 Si Siv
95. T.A. McDonagh, M. Komajda, A.P. Maggioni Clinical trials in acute heart failure: simpler solutions to complex problems Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009 Eur J Heart Fail 13 2011 1253 1260
96. B. Westendorp, R.G. Schoemaker, H. Buikema, F. Boomsma, D.J. van Veldhuisen, W.H. van Gilst Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction Eur J Heart Fail 8 2006 122 130 (Pubitemid 43240844)
97. P.A. Scott, G.H. Kingsley, D.L. Scott Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials Eur J Heart Fail 10 2008 1102 1107
98. J.R. Prowle, J.E. Echeverri, E.V. Ligabo, C. Ronco, R. Bellomo Fluid balance and acute kidney injury Nat Rev Nephrol 6 2010 107 115
99. J.R. Chiong, R.J. Cheung Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue Clin Cardiol 33 2010 345 352
100. W.F. Peacock, M.R. Costanzo, T. De Marco Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry Cardiology 113 2009 12 19
101. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
102. C. Ronco, D. Cruz, B. Noland Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome Semin Nephrol 32 2012 121 128
103. D.B. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases BMC Med Genomics 2 2009 2
104. S. Lele, S. Shah, P.A. McCullough, M. Rajapurkar Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes EuroIntervention 5 2009 336 342
105. S.V. Shah, M.M. Rajapurkar The role of labile iron in kidney disease and treatment with chelation Hemoglobin 33 2009 378 385
106. A. Whaley-Connell, J.R. Sowers, P.A. McCullough The role of oxidative stress in the metabolic syndrome Rev Cardiovasc Med 12 2011 21 29
107. P.A. McCullough, T. Omland, A.S. Maisel B-type natriuretic peptides: a diagnostic breakthrough for clinicians Rev Cardiovasc Med 4 2003 72 80 (Pubitemid 36701300)
108. D. Sica, R.M. Oren, M.D. Gottwald, R.M. Mills Scios 351 Investigators Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction Clin Cardiol 33 2010 330 336
109. D.N. Cruz, C.Y. Goh, A. Haase-Fielitz, C. Ronco, M. Haase Early biomarkers of renal injury Congest Heart Fail 16 Suppl 1 2010 S25 S31
110. K. Mori, H.T. Lee, D. Rapoport Endocytic delivery of lipocalin- siderophore-iron complex rescues the kidney from ischemia-reperfusion injury J Clin Invest 115 2005 610 621 (Pubitemid 40322235)
111. M. Haase, R. Bellomo, A. Haase-Fielitz Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury J Am Coll Cardiol 55 2010 2024 2033
112. A.S. Maisel, C. Mueller, R. Fitzgerald Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial Eur J Heart Fail 13 2011 846 851